Sort by:
- Doctors (2)
- Locations (2)
Alejandro (Alex) Lichtinger
Contact Info
Office Hours
- Today
- -
Alejandro (Alex) Lichtinger
About Alejandro (Alex) Lichtinger
Dr. Lichtinger finished his medical degree at Mexico’s Anáhuac University, before completing an ophthalmology residency at the Hebrew University of Jerusalem in Israel, during which time he was named chief resident and graduated with highest distinction.
He went on to complete fellowships in cornea, external diseases, and refractive surgery at both the University of Toronto and the University of California San Diego as well as a cornea, cataract, and refractive surgery fellowship at the CODET Vision Institute in Tijuana, Mexico.
Dr. Lichtinger is an experienced ophthalmologist who specialises in Phakic IOL Implantation and treating cataracts as well as corneal conditions. He is currently on staff at Miramichi Regional Hospital’s Department of Surgery. He previously worked as a physician at the Hospital Angeles de las Lomas in México.
Dr. Lichtinger is currently an assistant professor in the Department of Ophthalmology and Visual Sciences at Dalhousie University. He’s also an assistant professor at the Instituto de Oftalmologia Conde de Valenciana in Mexico City. He is a talented researcher who has been published on numerous occasions, including in journals such as Ophthalmology, the Journal of Cataract and Refractive Surgery, and Cornea.
During his fellowship at the University of Toronto, Dr. Lichtinger was honoured with the Lim Family Memorial Award, which is presented by ophthalmology residents to the fellow that displayed superior surgical, clinical, and interpersonal skills. He also won the University of Toronto’s John Gaby Prize for the best research paper by an ophthalmology fellow.
Select Your Region
Latin America
References
1. Patient Survey, STAAR Surgical ICL Data Registry, 2018
2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018
3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
Important Safety Information
The EVO/EVO+ ICLs are indicated for patients who are 21 to 60 years of age and are available in spherical powers ranging from -3.0 D to -18.0 D for the correction/reduction of myopia with or without a cylinder power range from 1.0 D to 6.0 D. The hyperopic ICLs are indicated for patients who are 21 to 45 years of age and are available in powers ranging from +3.0 D to +10.0 D for the correction/reduction of hyperopia. In order to be sure that your surgeon will use an ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/ adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctiva I irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.